QuidelOrtho Corporation (QDEL)
NASDAQ: QDEL · Real-Time Price · USD
27.76
-0.06 (-0.22%)
At close: Dec 5, 2025, 4:00 PM EST
28.03
+0.27 (0.99%)
After-hours: Dec 5, 2025, 7:46 PM EST
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2015 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 28, 2025 | Dec '24 Dec 29, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 2, 2022 | 2015 - 2020 |
| North America Revenue | 1.50B | 1.62B |
Log In |
Log In |
Log In | Upgrade
|
| EMEA Revenue | 353.90M | 335.80M |
Log In |
Log In |
Log In | Upgrade
|
| China Revenue | 329.90M | 325.00M |
Log In |
Log In |
Log In | Upgrade
|
| Other Geographies Revenue | 532.20M | 502.30M |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Total) | 2.71B | 2.78B |
Log In |
Log In |
Log In | Upgrade
|
Revenue
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2015 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 28, 2025 | Dec '24 Dec 29, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 2, 2022 | 2015 - 2020 |
| Labs Revenue | 1.47B | 1.43B |
Log In |
Log In |
Log In | Upgrade
|
| Immunohematology Revenue | 539.50M | 522.60M |
Log In |
Log In |
Log In | Upgrade
|
| Donor Screening Revenue | 60.60M | 115.50M |
Log In |
Log In |
Log In | Upgrade
|
| Transfusion Medicine Revenue | 600.10M | 638.10M |
Log In |
Log In |
Log In | Upgrade
|
| Point of Care Revenue | 613.20M | 694.10M |
Log In |
Log In |
Log In | Upgrade
|
| Molecular Diagnostics Revenue | 24.80M | 24.00M |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Other) | 3.70M | - |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Total) | 2.71B | 2.78B |
Log In |
Log In |
Log In | Upgrade
|
Adjusted EBITDA by Geography
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2015 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 28, 2025 | Dec '24 Dec 29, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 2, 2022 | 2015 - 2020 |
| North America Adjusted EBITDA | - | 892.10M |
Log In |
Log In |
Log In | Upgrade
|
| EMEA Adjusted EBITDA | - | 46.50M |
Log In |
Log In |
Log In | Upgrade
|
| China Adjusted EBITDA | - | 130.50M |
Log In |
Log In |
Log In | Upgrade
|
| Other Geographies Adjusted EBITDA | - | 133.50M |
Log In |
Log In |
Log In | Upgrade
|
| Corporate Adjusted EBITDA | - | -659.70M |
Log In |
Log In |
Log In | Upgrade
|
| Operating Income (Other) | -953.30M | -2.50B |
Log In |
Log In |
Log In | Upgrade
|
| Operating Income (Total) | -953.30M | -1.96B |
Log In |
Log In |
Log In | Upgrade
|